Jones James's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) · filed May 6, 2022
- Accession no.
- 0001209191-22-027649
- Filed
- May 6, 2022
- Trade date
- Apr 14-29, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions. Open-market purchases total $830.3. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jones JamesCIK 0001490829 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.71 | +$75.88 | 20,393 | Direct | |
| Apr 18, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.63 | +$73.64 | 20,421 | Direct | |
| Apr 19, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.69 | +$75.32 | 20,449 | Direct | |
| Apr 20, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.74 | +$76.72 | 20,477 | Direct | |
| Apr 21, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.75 | +$77 | 20,505 | Direct | |
| Apr 22, 2022 | Common Stock | PPurchaseAcquired | +28 | $2.73 | +$76.44 | 20,533 | Direct | |
| Apr 25, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.62 | +$78.6 | 20,563 | Direct | |
| Apr 26, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.53 | +$75.9 | 20,593 | Direct | |
| Apr 27, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.41 | +$72.3 | 20,623 | Direct | |
| Apr 28, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.51 | +$75.3 | 20,653 | Direct | |
| Apr 29, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.44 | +$73.2 | 20,683 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.